400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / CRF Receptor / Verucerfont
CAS No.: 885220-61-1
Synonyms: GSK561679;SK-561679;NBI-77860
GSK561679 is a CRF-1 antagonist. Verucerfont blocks the CRH-1 receptor, and so reduces ACTH release following chronic stress. It is under investigation as a potential treatment for alcoholism.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01814332 | Stress Disorders, Post-traumat... more >>ic Collapse << | Phase 2 | Completed | - | United States, California ... more >> San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States, 94121 Collapse << |
NCT01814332 | - | - | Completed | - | - |
NCT01059227 | - | - | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
实验方案
技术信息
CAS号 | 885220-61-1 | 储存条件 |
|
|
分子式 | C22H26N6O2 | 运输 | 蓝冰 | |
分子量 | 406.48 | 别名 | GSK561679;SK-561679;NBI-77860;SK-561,679 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01814332 | Stress Disorders, Post-traumat... more >>ic Collapse << | Phase 2 | Completed | - | United States, California ... more >> San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States, 94121 Collapse << |
NCT01814332 | - | - | Completed | - | - |
NCT01059227 | - | - | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT02349503 | Congenital Adrenal Hyperplasia | Phase 1 | Withdrawn | October 2015 | United States, Michigan ... more >> Ann Arbor, Michigan, United States, 48109 United States, Washington Seattle, Washington, United States, 98105 Collapse << |
NCT00555139 | Social Phobia | Phase 1 | Completed | - | Spain ... more >> GSK Investigational Site Barcellona, Spain, 08025 GSK Investigational Site Barcelona, Spain, 08025 GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, E-08003 GSK Investigational Site Barcelona, Spain GSK Investigational Site Hospitalet de Llobregat, Spain, 08907 GSK Investigational Site Mataro (Barcelona), Spain GSK Investigational Site Sabadell (Barcelona), Spain, 08208 GSK Investigational Site Terrassa - Barcelona, Spain, 08227 Collapse << |
NCT00513565 | Depressive Disorder and Anxiet... more >>y Disorders Collapse << | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site La Jolla, California, United States, 92037 Collapse << |
NCT01187511 | Alcohol Dependence | Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT00426608 | Depressive Disorder and Anxiet... more >>y Disorders Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Collapse << |
NCT01187511 | - | - | Completed | - | - |
NCT00539136 | Healthy Subjects | Phase 1 | Completed | - | United States, Kentucky ... more >> GSK Investigational Site Lexington, Kentucky, United States, 40503 Collapse << |
NCT00733980 | Depressive Disorder, Major | Phase 2 | Completed | - | United States, California ... more >> GSK Investigational Site Cerritos, California, United States, 90703 GSK Investigational Site San Diego, California, United States, 92108 GSK Investigational Site Torrance, California, United States, 90502 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32216 GSK Investigational Site Miami, Florida, United States, 33125 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 GSK Investigational Site Marietta, Georgia, United States, 30060 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60612 GSK Investigational Site Skokie, Illinois, United States, 60076 United States, Louisiana GSK Investigational Site Shreveport, Louisiana, United States, 71104 United States, Maryland GSK Investigational Site Rockville, Maryland, United States, 20852 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87109 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27609 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45219-0516 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38119 United States, Wisconsin GSK Investigational Site Brown Deer, Wisconsin, United States, 53223 GSK Investigational Site Madison, Wisconsin, United States, 53719 Collapse << |
NCT00511563 | Irritable Bowel Syndrome | Phase 2 | Withdrawn(Cancelled before act... more >>ive due to the results of emerging scientific data) Collapse << | - | - |
NCT01018992 | - | - | Completed | - | - |
NCT01018992 | Stress Disorders, Post-Traumat... more >>ic Collapse << | Phase 2 | Completed | - | United States, California ... more >> Stress and Health Research Program, San Francisco VA Medical Center, University of California San Francisco San Francisco, California, United States, 94121 United States, Georgia Emory University Atlanta, Georgia, United States, 30306 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Collapse << |
NCT00733980 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网